Lineus Medical
Private Company
Total funding raised: $1.5M
Overview
Lineus Medical, founded in 2016 and headquartered in Fayetteville, Arkansas, has developed the SafeBreak Vascular device to address the high failure rate of peripheral IV lines. The device mechanically separates under tension to prevent catheter dislodgement and vein damage, with clinical data showing a 44% reduction in complications requiring IV restarts. As a private, commercial-stage company, Lineus Medical targets significant cost savings and workflow improvements for hospitals by reducing supply waste, medication spills, and nurse labor associated with frequent IV replacements.
Technology Platform
Proprietary in-line breakaway device with dual-valve sealing mechanism designed to separate under harmful tension to protect IV catheters from dislodgement and prevent fluid leaks.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
SafeBreak Vascular appears to be first-to-market as an FDA-cleared breakaway device for all vascular access lines. Traditional competition consists of standard IV securement devices (e.g., dressings, stabilizers) that do not address tensile force. Potential future competitors include other startups or divisions of large infusion therapy companies (e.g., Becton Dickinson, ICU Medical, B. Braun) that could develop similar in-line protection devices.